ЯВЛЯЕТСЯ ЛИ УПОТРЕБЛЕНИЕ АЛКОГОЛЯ ФАКТОРОМ РИСКА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК?


Цитировать

Полный текст

Аннотация

Представлены и проанализированы данные, обосновывающие и опровергающие значение регулярного употребления алкоголя как фактора риска хронической болезни почек.

Об авторах

- -

Список литературы

  1. Мухин Н.А. Профилактическая нефрология и образ жизни современного человека // Терапевтический архив. 1993. № 6. С. 4-7.
  2. Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология и диализ. 2005. № 3. С. 7-15.
  3. Orth S.R. Smoking - a renal risk factor. Nephron 2000;86(1):12-26.
  4. Perneger T.V., Whelton P.K., Klag M.J. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1994;331(25):1675-1679.
  5. Chung C.H., Yang Y.H., Wang T.Y. et al. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J. Oral. Pathol. Med. 2005;34(8):460-466.
  6. Chang W.C., Hsiao C.F., Chang H.Y. et al. Betel nut chewing and other risk factors associated with obesity among Taiwanese male adults. Int. J. Obes. (Lond.) 2006;30(2):359-363.
  7. Lin W.Y., Pi-Sunyer F.X., Liu C.S. et al. Betel nut chewing is strongly associated with general and central obesity in Chinese male middle-aged adults. Obesity (Silver Spring). 2009;17(6):1247-1254.
  8. Lin W.Y., Chiu T.Y., Lee L.T. et al. Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. Am. J. Clin. Nutr. 2008; 87(5): 1204-1211
  9. Chou C.Y., Cheng S.Y., Liu J.H. et al. Association between betel-nut chewing and chronic kidney disease in men. Public Health Nutr. 2009;12(5):723-727.
  10. Огурцов П.П., Нужный В.П. Экспресс-диагностика (скрининг) хронической алкогольной интоксикации у больных соматического профиля // Клиническая фармакология и терапия. 2001. № 1. С. 34-39.
  11. Моисеев В.С., Огурцов П.П. Алкогольная болезнь: патогенетические, диагностические и клинические аспекты // Терапевтический архив. 1997. № 12. С. 5-12.
  12. Talaie H., Pajouhmand A., Abdollahi M. et al. Rhabdomyolysis among acute human poisoning cases. Hum. Exp. Toxicol. 2007;26(7):557-561.
  13. Kraut J.A., Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis and management. Clin. J. Am. Soc. Nephrol. 2008;3:208-225.
  14. Мухин Н.А., Балкаров И.М. Подагрическая почка. В: Тареева И.Е. (ред.) Нефрология: руководство для врачей. М., 2000. С. 422-428.
  15. Лебедева М.В., Балкаров И.М., Шовская Т.Н. Острая уратная нефропатия - причина обратимой почечной недостаточности у молодого больного // Терапевтический архив. 2006. №78(5). С. 69-71.
  16. Domrongkitchaiporn S., Sritara P., Kitiyakara C. et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J. Am. Soc. Nephrol. 2005;16(3):791-799.
  17. Chen N., Wang W., Huang Y. et al. Community-based study on CKD subjects and the associated risk factors. Nephrol. Dial. Transplant. 2009;24(7):2117-2123.
  18. Borges R.L., Hirota A.H., Quinto B.M. et al. Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J. Clin. Hypertens. (Greenwich). 2009;11(5):253-259.
  19. Suliman M.E., Johnson R.J., García-Lopez E. et al. J-shaped mortality relationship for uric acid in CKD. Am. J. Kidney Dis. 2006;48(5):761-771.
  20. Kang D.-H., Nakagawa T., Feng L. et al. A role of uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 2002;13:2888-2897.
  21. Мухин Н.А., Шоничев Д.Г., Балкаров И.М. и соавт. Формирование артериальной гипертонии при уратном тубулоинтерстициальной поражении почек // Терапевтический архив. 1999. № 6. С. 12-24.
  22. Sanchez-Lozada L.G., Tapia E., Santamaría J. et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67(1):237-247.
  23. Choi H.K., Gurhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004;51(6):1023-1029.
  24. Sugie T., Imatou T., Miyazaki M., Une H. The effect of alcoholic beverage type on hyperuricemia in Japanese male office workers. J. Epidemiol. 2005;15(2):41-47.
  25. Yu K.H., See L.C., Huang Y.C. et al. Dietary factors associated with hyperuricemia in adults. Semin. Arthritis Rheum. 2008;37(4):243-250.
  26. Shiraishi H., Une H. The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. J. Epidemiol. 2009;19(1):12-16.
  27. Shankar A., Klein R., Klein B.E. The association among smoking, heavy drinking, and chronic kidney disease. Am. J. Epidemiol. 2006;164(3):263-271.
  28. Yamagata K., Ishida K., Sairenchi T. et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159-166.
  29. White S.L., Polkinghorne K.R., Cass A. et al. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol. Dial. Transplant. 2009; 24(8):2464-2472.
  30. Reynolds K., Gu D., Chen J. et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73(7):870-876.
  31. Perneger T.V., Whelton P.K., Puddey I.B., et al. Risk of end-stage renal disease associated with alcohol consumption. Am. J. Epidemiol. 1999;150(12):1275-1281.
  32. Peters H., Martini S., Woydt R. et al. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis. Am. J. Physiol. Renal. Physiol. 2003;284(5):F1105-F1114.
  33. Vasdev S., Ford C.A., Longerich L. et al. Antihypertensive effect of low ethanol intake in spontaneously hypertensive rats. Mol. Cell. Biochem. 1999;200(1-2):85-92.
  34. Vasdev S., Gill V., Parai S., et al. Low ethanol intake prevents salt-induced hypertension in WKY rats. Mol. Cell Biochem. 2006;287(1-2):53-60.
  35. Российское Медицинское Общество по Артериальной Гипертонии - Всероссийское Научное Общество Кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр.). М., 2008.
  36. Calhoun D.A., Jones D., Textor S. et al. Resistant hypertension: diagnosis, evaluation and teratment: A scientific statement form the American Heart Association professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510-e526.
  37. Tirapelli C.R., Legros E., Brochu I. et al. Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats. Br. J. Pharmacol. 2008;154(5):971-981.
  38. Tumlin J.P., Madaio M.P., Hennigar R. Idiopathic IgA nephropathy: pathogenesis, histopathology and therapeutic options. Clin. J. Am. Soc. Nephrol. 2004;2:1054-1061.
  39. Smith S.M., Yu G.S., Tsukamoto H. IgA nephropathy in alcohol abuse. An animal model. Lab. Invest. 1990;62(2):179-184.
  40. Smith S.M., Leaber R., Lefebre A. et al. Pathogenesis of IgA nephropathy in ethanol consumption: animal model and cell culture studies. Alcohol. 1993;10(6):477-480.
  41. Wakai K., Kawamura T., Matsuo S. et al. Risk factors for IgA nephropathy: a case-control study in Japan. Am. J. Kidney Dis. 1999;33(4):738-745.
  42. Wakai K., Nakai S., Matsuo S. et al. Risk factors for IgA nephropathy: a case-control study with incident cases in Japan. Nephron. 2002;90(1):16-23.
  43. Kaartinen K., Niemela O., Syrjanen J. et al. Alcohol consumption and kidney function in IgA glomerulonephritis. Nephron. Clin. Pract. 2009;112(2):c86-c93.
  44. Stefanovic V., Cukuranovic R., Miljkovic S. et al. Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method. Ren. Fail. 2009;31(5):409-418.
  45. Gueye A.S., Chelamcharla M., Baird B.C. et al. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol. Dial. Transplant. 2007;22(3):891-898.
  46. Hu J., Chen Y., Mao Y. et al.; Canadian Cancer Registries Epidemiology Research Group. Alcohol drinking and renal cell carcinoma in Canadian men and women. Cancer Detect. Prev. 2008;32(1):7-14.
  47. Caimi G., Carollo C., Lo Presti R. Chronic renal failure: oxidative stress, endothelial dysfunction and wine. Clin. Nephrol. 2004;62(5):331-335.
  48. Presti R.L., Carollo C., Caimi G. Wine consumption and renal diseases: new perspectives. Nutrition. 2007;23(7-8):598-602.
  49. Gooderham P.A., Gagnon R.F., Gill K. Attenuation of the alcohol preference of C57BL/6 mice during chronic renal failure. J. Lab. Clin. Med. 2004;143(5):292-300.
  50. Vamvakas S., Teschner M., Bahner U. et al. Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin. Nephrol. 1998;49(4):205-213.
  51. De Marchi S., Cecchin E., Basile A. et al. Renal tubular dysfunction in chronic alcohol abuse-effects of abstinence. N. Engl. J. Med. 1993;329(26):1927-1934.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать